Search for: "C Lillie" Results 101 - 120 of 441
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Sep 2010, 6:10 pm by Kelly
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen, ‘yes’ to Member… [read post]
18 Jun 2020, 2:24 pm by Angela Mauroni
” Various drug manufacturers, including Merck, Eli Lilly, and Amgen were joined by the Association of National Advertisers in challenging the rule in June 2019. [read post]
20 Mar 2020, 4:45 am by Sophie Corke
Find Parts 1 and 2 here and here.Never Too Late 255 [Week ending March 1] Breaking news: UK will not participate in UPC system | Nothing to see here, Lilly wins in kicking out Genentech's Talz progeny patent (for now) | The Swedish Patent and Market Court of Appeal applies "Abraxis" in rejecting Supplementary Protection Certificate | How do you determine the novelty of a second (non-medical) use claim? [read post]
18 Apr 2016, 12:46 am
| Actavis v Lilly | EU public consultation on neighbouring rights | Life as an IP Lawyer in San Francisco | Copyright in chess games | Trade surplus and IP | Fujifilm Kyowa Biologics v AbbVie Biotechnology.Never too late 88 [week ending on Sunday 20 March] – CoA’s decision in Design & Display Limited v OOO Abbott & another | AG in McFadden C-484/14 on WiFi providers’ liability | Twitter on “Dronie”… [read post]
19 Jun 2017, 1:00 am by Matrix Legal Support Service
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
11 Mar 2016, 1:25 pm by Rebecca Tushnet
  Difficulty may arise b/c of confidentiality clauses. [read post]
12 Aug 2010, 11:28 am by Bexis
  Id. at 8-9 ("[c]ausing a subpoena to be served, with notice that compliance with it by the complicit recipient would violate a court’s lawful order, cannot be characterized as 'legitimate'”). [read post]
3 Jun 2010, 11:25 am by Steve Bainbridge
In 2008, the company was sold to the pharmaceutical giant Eli Lilly for $6.5 billion. [read post]
24 Oct 2011, 2:52 am by Laura Sandwell
Human Genome Sciences Inc v Eli Lilly and Company, heard 18 July 2011. [read post]
24 Oct 2011, 2:52 am by Laura Sandwell
Human Genome Sciences Inc v Eli Lilly and Company, heard 18 July 2011. [read post]
7 Nov 2007, 6:57 pm by Christopher S. Jones
”You can read the Order, dated August 17th, 2007, on Acquirelaw™ at In re Eli Lilly & Co. [read post]
3 Apr 2017, 1:00 am by Matrix Legal Support Service
On Tuesday 4 April until Thursday 6 April, the Supreme Court will hear the appeal of Eli Lilly & Co v Actavis UK Ltd & Ors, and other cases. [read post]
1 Jun 2017, 9:45 am by Barbara Moreno
PSYCHOLOGY AND PSYCHIATRY Singh, Lilly, How to be a Bawse: A Guide to Conquering Life (2017). [read post]
16 Aug 2011, 10:31 am by Glenn Reynolds
There’s a Pfizer compound that hits JAK1/2/3 that’s already been through some Phase III work, a Novartis/Incyte compound that hits JAK1 and JAK2, which is now in Phase III, and a Lilly/Incyte compound that also hits JAK1 and JAK2 that’s in Phase II. [read post]
9 Sep 2015, 10:03 am
 IP Tango, the bilingual Latin American blog, hosts an account by Magda Voltolini of a spot of sham litigation in Brazil on the part of pharma giant Eli Lilly. [read post]
26 Feb 2016, 7:20 am by Tom Lamb
On the other hand, it increases low density lipoprotein cholesterol (LDL-C), and impairs the glomerular filtration rates, both by small amounts on the average. [read post]
3 Aug 2011, 3:31 am by Marie Louise
322/10 Medeva v Comptroller-General of Patents, Designs and Trade Marks and C? [read post]